Wager O, Penttinen K, Almeida J D, Opromolla D V, Godal T, Kronvall G
Clin Exp Immunol. 1978 Dec;34(3):326-37.
Sera from 135 patients with leprosy were tested by the platelet aggregation test (PAT), by the Rubino test and by other sero-immunological assays. PAT positivity (titre≥10) was 53% in the lepromatous subgroups and 5% in the tuberculoid subgroups (<0·005). The higher PAT titres and Rubino titres clustered significantly (<0·0005) toward the lepromatous end of the disease spectrum. A statistically significant correlation was found between the PAT and the Rubino titres (0·05>>0·025). Removal of the effect of the disease spectrum, however, resulted in a partial correlation between the PAT and the Rubino titres that was not significant (>0·1), suggesting different basic mechanisms for the platelet aggregation (PA) and the Rubino activity of the lepromatous sera. The correlation between the PAT titres and twenty-nine other sero-immunological parameters was calculated, and a highly significant correlation was found between the PAT and the IgG level (<0·005) and between the PAT and the antistaphylolysin-α titre (<0·005). The PA activity in most lepromatous sera studied sedimented in the heavy (>19S) fractions and was inhibitable by IgM rheumatoid factor. It thus fulfilled the criteria for IgG complexes as defined in previous studies with known model Ag/Ab complexes and with sera from patients with immune complex states. The addition of an excess of soluble mycobacterial antigens affected the PA activity of some lepromatous sera, which suggests that the putative complexes were composed of mycobacterial antigens complexed with corresponding IgG antibody. It was concluded that the PAT is a sensitive detector of IgG complexes peculiar to the lepromatous leprosy. In leprosy the discriminatory power of the PAT seems to be superior to that of other immune complex tests recently applied for the analysis of leprosy series.
采用血小板聚集试验(PAT)、鲁比诺试验及其他血清免疫学检测方法,对135例麻风患者的血清进行检测。在瘤型亚组中,PAT阳性(滴度≥10)率为53%,在结核样型亚组中为5%(<0.005)。较高的PAT滴度和鲁比诺滴度显著聚集于疾病谱的瘤型一端(<0.0005)。发现PAT与鲁比诺滴度之间存在统计学显著相关性(0.05>>0.025)。然而,去除疾病谱的影响后,PAT与鲁比诺滴度之间的偏相关性不显著(>0.1),提示瘤型血清的血小板聚集(PA)和鲁比诺活性存在不同的基本机制。计算了PAT滴度与其他29项血清免疫学参数之间的相关性,发现PAT与IgG水平(<0.005)以及PAT与抗葡萄球菌溶血素-α滴度(<0.005)之间存在高度显著相关性。在大多数研究的瘤型血清中,PA活性沉淀于重(>19S)组分中,且可被IgM类风湿因子抑制。因此,它符合先前关于已知模型抗原/抗体复合物及免疫复合物状态患者血清研究中所定义的IgG复合物标准。加入过量可溶性分枝杆菌抗原会影响某些瘤型血清的PA活性,这表明假定的复合物由分枝杆菌抗原与相应的IgG抗体复合而成。得出结论:PAT是瘤型麻风特有的IgG复合物的敏感检测方法。在麻风病中,PAT的鉴别能力似乎优于最近用于麻风病系列分析的其他免疫复合物检测方法。